Stephens & Co. Maintains Equal-Weight on Health Catalyst, Lowers Price Target to $1.75

Benzinga Newsdesk www.benzinga.com Neutral 67.5%

Neg 0% Neu 67.5% Pos 0%

Stephens & Co. analyst Jeff Garro maintains Health Catalyst (NASDAQ:HCAT) with a Equal-Weight and lowers the price target from $2 to $1.75.